Eisai, Biogen secure Leqembi FDA accelerated approval for Alzheimer’s disease

Eisai and Biogen have secured the approval of the US Food and Drug Administration (FDA) for their jointly developed Leqembi (lecanemab-irmb) under the accelerated approval ... Read More